- 1. 4B5 monoclonal antibody anti-idiotype vaccine
- [A humanized anti-idiotypic (anti-Id) monoclonal antibody (MoAb) that mimics the disialoganglioside GD2, a cancer-associated antigen present on melanoma, small cell lung cancer, sarcoma, neuroblastoma and other malignancies. GD2 is a highly expressed glycosphingolipid by melanoma and other neuroectodermal tumors with only minimal expression on normal tissues. Vaccination with anti-Id 4B5 IgG was capable of eliciting both cellular and humoral immune responses against GD2 expression tumor cells. ( NCI )] (UMLS (NCI) C0879386) MoAb 4B5 anti-idiotype vaccine;
Monoclonal Antibody 4B5 Anti-Idiotype Vaccine =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 45. BMP5
- [Bone Morphogenetic Protein 5, encoded by the BMP5 gene, is a member of the TGF-beta family of growth factors. Morphogenetic Protein 5 signals through receptor serine/threonine kinases and induces cartilage and bone formation. It is expressed in the lungs and liver. (NCI) ( NCI )] (UMLS (NCI) C0537464) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 2. 8B-[(Methylthio)methyl]-6-propylergoline Monomethanesulfonate
- [A semi-synthetic ergot derivative and a dopamine agonist with antiparkinson property. Pergolide mesylate binds to and activates dopamine receptor subtypes D1 and D2, resulting in prolactin secretion inhibition, transient increase in serum concentration of growth hormone, and decrease in serum concentration of luteinizing hormone. Direct stimulation of postsynaptic dopamine receptors in the nigrostriatal system, may account for this agent's antiparkinson activity. ( NCI )] (UMLS (NCI) C0031008) =Organic Chemical; Pharmacologic Substance =PERGOLIDE;
=PERGOLIDE MESYLATE 0.05 MG;
PERGOLIDE MESYLATE 0.25 MG;
PERGOLIDE MESYLATE 1 MG | - 46. BMP5
- [This gene plays a role in the regulation of mesenchymal differentiation. It is involved in cartilage and bone formation. ( NCI )] (UMLS (NCI) C1332426) BMP5 Gene;
Bone Morphogenetic Protein 5 Gene;
=Gene or Genome |
- 3. B Melanoma Antigen
- [The BAGE gene family encodes CT antigens, recognized by cytotoxic T-lymphocytes. BAGE is expressed in normal adult testis and in some melanomas, infiltrating bladder carcinomas, mammary carcinomas, head and neck squamous cell carcinomas, and non-small cell lung carcinomas. The function of BAGE protein is unknown. ( NCI )] (UMLS (NCI) C1447354) BAGE;
BAGE Tumor Antigen =Amino Acid, Peptide, or Protein; Immunologic Factor | - 47. BMP6
- [Bone morphogenetic protein 6, encoded by the BMP6 gene, is a member of the TGF-beta family. It has strong similarity to murine Bmp6, signals through receptor serine/threonine kinases, and is involved in endochondral bone formation. (From LocusLink) ( NCI )] (UMLS (NCI) C0537467) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 4. B16 Malignant Melanoma
- (UMLS (NCI) C0004565) =Experimental Model of Disease; Neoplastic Process
| - 48. BMP6
- [This gene plays a role in enchondral bone formation. It is also involved in promoting the growth of dendrites. ( NCI )] (UMLS (NCI) C1332427) BMP6 Gene;
Bone Morphogenetic Protein 6 Gene;
=Gene or Genome |
- 5. B2M
- [This gene plays a role in immune responses. ( NCI )] (UMLS (NCI) C1412709) B2M Gene;
Beta-2-Microglobulin Gene =Gene or Genome ;
| - 49. BMP7
- [Bone Morphogenetic Protein 7 (BMP7), encoded by the BMP7 gene, is a member of the TGF-beta family. BMP7 signals through receptor serine/threonine kinases and has very strong similarity to murine Bmp7. BMP7 plays a role in calcium regulation and bone homeostasis. It induces cartilage and bone formation and may be the osteoinductive factor responsible for the phenomenon of epithelial osteogenesis. BMP7 is expressed in the kidney and bladder and lower levels are seen in the brain. At all anatomical sites disrupted by Holt-Oram syndrome mutations, BMP7 is expressed in all structures that are altered in Holt-Oram Syndrome patients, including the heart, proximal and distal forelimb, clavicle, and scapula, as well as other unaffected tissues. (NCI) ( NCI )] (UMLS (NCI) C0083867) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 6. BM
- [A country in Southeastern Asia, bordering the Andaman Sea and the Bay of Bengal, between Bangladesh and Thailand. (NCI) ( NCI )] (UMLS (NCI) C0006416) =Geographic Area ;
| - 50. BMP7
- [This gene is involved in calcium regulation and bone homeostasis. It also plays a role in the control of cellular development and differentiation. ( NCI )] (UMLS (NCI) C1332428) BMP7 Gene;
Bone Morphogenetic Protein 7 Gene;
=Gene or Genome |
- 7. BM 10 188
- [A synthetic partial beta-adrenergic agonist with sympathomimetic activity. Doxaminol may bind to and stimulate beta-1-adrenergic receptors located in the myocardium. As a result, it leads to a positive inotropic effect and increases in cardiac output. ( NCI )] (UMLS (NCI) C0058717) =Organic Chemical; Pharmacologic Substance
| - 51. BMP8
- [Bone morphogenetic protein 8 (BMP8), encoded by the BMP8 gene, is a member of the TGF-beta family of growth factors and signals through receptor serine/threonine kinases. BMP8 plays a role in calcium regulation and bone homeostasis. It induces cartilage and bone formation and may be the osteoinductive factor responsible for the phenomenon of epithelial osteogenesis. (NCI) ( NCI )] (UMLS (NCI) C0527442) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 8. BM 12.531
- (UMLS (NCI) C0053865) =Organic Chemical; Pharmacologic Substance ;
| - 52. BMP8B
- [This gene plays a role in calcium regulation and bone homeostasis. It is involved in cartilage and bone formation. ( NCI )] (UMLS (NCI) C1412806) BMP8B Gene;
Bone Morphogenetic Protein 8b (Osteogenic Protein 2) Gene =Gene or Genome |
- 9. BMD
- [Various methods to measure how many grams of calcium and other bone minerals, collectively known as bone mineral content, are present in a segment of bone. ( NCI )] (UMLS (NCI) C0177804) =Diagnostic Procedure
| - 53. BMPR1A
- [The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. Germline mutations in BMPR1A cause a subset of juvenile polyposis syndrome and Cowden syndrome. (From LocusLink) ( NCI )] (UMLS (NCI) C0662917) =Amino Acid, Peptide, or Protein; Receptor ;
|
- 10. BMI
- [A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI) ( NCI )] (UMLS (CSP) C1305855) BODY MASS INDEX;
Body mass index [BMI];
Quetelet Index =Clinical Attribute ;
| - 54. BMPR1A
- [This gene plays a role in the bone morphogenetic protein signaling pathway. ( NCI )] (UMLS (NCI) C1332430) BMPR1A Gene;
Bone Morphogenetic Protein Receptor, Type IA Gene;
=Gene or Genome |
- 11. BMI 25.0-25.9,ADULT
- [ ] (UMLS (ICD9CM) C1561712) Body Mass Index 25.0-25.9, adult;
=Finding | - 55. BMPR2
- [Encoded by human BMPR2 Gene (BMP Receptor Family), Bone Morphogenetic Protein Receptor Type II is a type II transmembrane serine/threonine kinase receptor for BMPs, which are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. BMP receptors transduce their signals through the formation of heteromeric complexes of 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling; type I receptors require their respective type II receptors for ligand binding. Mutations in this gene have been associated with primary pulmonary hypertension. (NCI) ( NCI )] (UMLS (NCI) C0299048) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
|
- 12. BMI 26.0-26.9,ADULT
- [ ] (UMLS (ICD9CM) C1561713) Body Mass Index 26.0-26.9, adult;
=Finding | - 56. BMPR2
- [This gene is involved in receptor mediated ligand-induced signal transduction that is critical for endochondral bone formation and embryogenesis. ( NCI )] (UMLS (NCI) C1332431) BMPR2 Gene;
Bone Morphogenetic Protein Receptor, Type II (Serine/Threonine Kinase) Gene;
=Gene or Genome |
- 13. BMI 27.0-27.9,ADULT
- [ ] (UMLS (ICD9CM) C1561714) Body Mass Index 27.0-27.9, adult;
=Finding | - 57. BMS 247550
- [A substance that is being studied as a treatment for cancer. ( NCI )] (UMLS (NCI) C0879430) BMS247550;
BMS-247550;
Epothilone-B BMS 247550 =Organic Chemical; Pharmacologic Substance ;
|
- 14. BMI 28.0-28.9,ADULT
- [ ] (UMLS (ICD9CM) C1561715) Body Mass Index 28.0-28.9, adult;
=Finding | - 58. BMS 247616
- (UMLS (NCI) C0763682) BMS-247616;
=Organic Chemical; Pharmacologic Substance ;
|
- 15. BMI 29.0-29.9,ADULT
- [ ] (UMLS (ICD9CM) C1561716) Body Mass Index 29.0-29.9, adult;
=Finding | - 59. BMS-181176
- (UMLS (NCI) C0296895) =Organic Chemical; Antibiotic
|
- 16. BMI 30.0-30.9,ADULT
- [ ] (UMLS (ICD9CM) C1561718) Body Mass Index 30.0-30.9, adult;
=Finding | - 60. BMS-182751
- [A platinum compound used in chemotherapy. ( NCI )] (UMLS (NCI) C1328262) =Organic Chemical; Pharmacologic Substance ;
|
- 17. BMI 31.0-31.9,ADULT
- [ ] (UMLS (ICD9CM) C1561719) Body Mass Index 31.0-31.9, adult;
=Finding | - 61. BMS-182751/Etoposide
- (UMLS (NCI) C0281662) =Therapeutic or Preventive Procedure ;
|
- 18. BMI 32.0-32.9,ADULT
- [ ] (UMLS (ICD9CM) C1561720) Body Mass Index 32.0-32.9, adult;
=Finding | - 62. BMS-182751/PRED
- (UMLS (NCI) C0678095) =Therapeutic or Preventive Procedure
|
- 19. BMI 33.0-33.9,ADULT
- [ ] (UMLS (ICD9CM) C1561721) Body Mass Index 33.0-33.9, adult;
=Finding | - 63. BMS-186295
- [ ] (UMLS (CSP) C0288170) =Organic Chemical; Pharmacologic Substance
|
- 20. BMI 34.0-34.9,ADULT
- [ ] (UMLS (ICD9CM) C1561722) Body Mass Index 34.0-34.9, adult;
=Finding | - 64. BMS-188667
- (UMLS (NCI) C0378942) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 21. BMI 35.0-35.9,ADULT
- [ ] (UMLS (ICD9CM) C1561723) Body Mass Index 35.0-35.9, adult;
=Finding | - 65. BMS-188797
- [A substance that is being studied as a treatment for cancer. ( NCI )] (UMLS (NCI) C0879485) =Organic Chemical
|
- 22. BMI 36.0-36.9,ADULT
- [ ] (UMLS (ICD9CM) C1561724) Body Mass Index 36.0-36.9, adult;
=Finding | - 66. BMS-188797/Carboplatin
- (UMLS (NCI) C0879600) =Therapeutic or Preventive Procedure
|
- 23. BMI 37.0-37.9,ADULT
- [ ] (UMLS (ICD9CM) C1561725) Body Mass Index 37.0-37.9, adult;
=Finding | - 67. BMS-207147
- (UMLS (NCI) C0754490) =Organic Chemical; Pharmacologic Substance
|
- 24. BMI 38.0-38.9,ADULT
- [ ] (UMLS (ICD9CM) C1561726) Body Mass Index 38.0-38.9, adult;
=Finding | - 68. BMS-214662
- [A substance that is being studied as a treatment for cancer. ( NCI )] (UMLS (NCI) C0879424) FTI BMS 214662 =Organic Chemical; Pharmacologic Substance ;
|
- 25. BMI 39.0-39.9,ADULT
- [ ] (UMLS (ICD9CM) C1561727) Body Mass Index 39.0-39.9, adult;
=Finding | - 69. BMS-214662/Paclitaxel
- (UMLS (NCI) C0879583) =Therapeutic or Preventive Procedure
|
- 26. BMI 40 AND OVER,ADULT
- [ ] (UMLS (ICD9CM) C1561729) Body Mass Index 40 and over, adult;
=Finding | - 70. BMS-214662/Trastuzumab
- (UMLS (NCI) C1134463) =Therapeutic or Preventive Procedure
|
- 27. BMI BETWEEN 19-24,ADULT
- [ ] (UMLS (ICD9CM) C1561711) Body Mass Index between 19-24, adult;
=Finding | - 71. BMS-232632
- (UMLS (NCI) C0960815) =Organic Chemical; Pharmacologic Substance
|
- 28. BMI LESS THAN 19,ADULT
- [ ] (UMLS (ICD9CM) C1561710) Body Mass Index less than 19, adult;
=Finding | - 72. BMS-275183
- (UMLS (NCI) C1098058) =Organic Chemical
|
- 29. BMI,PEDIATRIC
- [ ] (UMLS (ICD9CM) C1719701) Body Mass Index, pediatric, less than 5th percentile for age =Clinical Attribute
| - 73. BMS-275291
- [A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called matrix metalloproteinase inhibitors (MMPIs). ( NCI )] (UMLS (NCI) C0935902) D2163;
N-((2S)-2-Mercapto-1-oxo-4-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)butyl)-L-leucyl-N,3-dimethyl-L-valinamide =Organic Chemical; Pharmacologic Substance ;
|
- 30. BMI,PEDIATRIC >= 95%
- [ ] (UMLS (ICD9CM) C1719704) Body Mass Index, pediatric, greater than or equal to 95th percentile for age =Clinical Attribute
| - 74. BMS-275291/Carboplatin/Paclitaxel
- (UMLS (NCI) C0935679) =Therapeutic or Preventive Procedure
|
- 31. BMI,PEDIATRIC 5% -
- [ ] (UMLS (ICD9CM) C1719702) Body Mass Index, pediatric, 5th percentile to less than 85th percentile for age =Clinical Attribute
| - 75. BMS-275291/Zoledronate
- (UMLS (NCI) C1134667) =Therapeutic or Preventive Procedure
|
- 32. BMI,PEDIATRIC 85% -
- [ ] (UMLS (ICD9CM) C1719703) Body Mass Index, pediatric, 85th percentile to less than 95th percentile for age =Clinical Attribute
| - 76. BMS-354825
- (UMLS (NCI) C1328005) =Organic Chemical; Pharmacologic Substance
|
- 33. BMI1
- [Involved in transcriptional repression, BMI1 heritably modifies chromatin, changing its expressibility. BMI1 may repress HOX genes as part of the Polycomb Complex to regulate segmental identity. BMI1 contains a ring-type, putative zinc finger and Polycomb-Group homology domain. BMI1 may complex with RING1. (from SWISS-PROT P35226, OMIM 164831, and NCI) ( NCI )] (UMLS (NCI) C0106701) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 77. BMS-387032
- (UMLS (NCI) C1451099) =Organic Chemical; Pharmacologic Substance ;
|
- 34. BMK1 Kinase
- [Highly expressed as four alternative transcripts in heart, placenta, lung, kidney, and skeletal muscle by human MAPK7 Gene (MAPK Family), 815-aa 88.6-kDa MAP Kinase 7 is a Ser/Thr kinase specifically activated by MAP2K5 (not MEK1/MEK2) and involved as an integration point for multiple downstream signals of various receptors, including receptor type kinases and GPCRs, in cell proliferation, differentiation, transcription regulation, and development. Autophosphorylated and likely activated by tyrosine and threonine phosphorylation by upstream kinase, MAPK7 translocates to the nucleus in response to extracellular signals and regulates gene expression by phosphorylating and activating target transcription factors. The C-terminus may have an autoregulatory role, and the second Pro-rich region may interact with actin, targeting MAPK7 to specific cell locations. (NCI) ( NCI )] (UMLS (NCI) C1174318) Extracellular Signal-Regulated Kinase 5;
MAP Kinase 7;
MAPK7;
=Amino Acid, Peptide, or Protein; Enzyme ;
| - 78. BMS186295
- [ ] (UMLS (CSP) C0872118) =Organic Chemical; Pharmacologic Substance
|
- 35. BMP
- [protein family consisting of 9 structurally related proteins belonging to the transforming growth factor beta superfamily. ( CSP )] (UMLS (CSP) C0053932) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=TGF;
| - 79. BMSCT
- [A procedure to replace bone marrow with deficient function, which could be caused by the aggressive chemotherapy and/or radiation treatment for cancer or other condition, by neoplastic process per se, or by variety of hematological and immunological diseases, with healthy bone marrow stem cells. Transplantation may be autologous (an individual's own cells harvested prior to treatment), allogeneic (cells from another person), or syngeneic (cells donated by an identical twin). ( NCI )] (UMLS (NCI) C0842093) Bone Marrow Stem Cell Transplantation =Therapeutic or Preventive Procedure
|
- 36. BMP10
- [This gene plays a role in cartilage and bone formation. It is involved in cellular growth and proliferation. ( NCI )] (UMLS (NCI) C1332422) BMP10 Gene;
Bone Morphogenetic Protein 10 Gene;
=Gene or Genome ◊ [Encoded by human BMP10 Gene (TGF-beta Family), 424-aa 48-kD homodimeric secreted Bone Morphogenetic Protein 10 is a putative growth factor that may signal through receptor serine/threonine kinases involved in trabeculation of the embryonic heart. (NCI) ( NCI )] (UMLS (NCI) C1332588) BMP-10; Bone Morphogenetic Protein 10; Amino Acid, Peptide, or Protein; Biologically Active Substance | - 80. BMT
- [transference of bone marrow within an individual, between individuals of the same species, or between individuals of different species. ( CSP )] (UMLS (CSP) C0005961) =Therapeutic or Preventive Procedure ;
=hematopoietic tissue transplantation;
=bone marrow purging;
|
- 37. BMP15
- [Bone Morphogenetic Protein 15 encoded by the BMP15 gene is a member of the bone morphogenetic protein family which is part of the transforming growth factor-beta superfamily. The transforming growth factor-beta superfamily includes large families of growth and differentiation factors. It is thought that this protein may be involved in oocyte maturation and follicular development as a homodimer or by forming heterodimers with a related protein, Gdf9. Bone morphogenetic protein 15 signals through receptor serine/threonine kinases. (From LocusLink) ( NCI )] (UMLS (NCI) C0905649) BMP-15;
Bone Morphogenetic Protein 15;
GDF-9B;
Growth/Differentiation Factor 9B =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 81. BMT Nephropathy
- [Kidney dysfunction resulting from complications of bone marrow transplantation. ( NCI )] (UMLS (NCI) C1332432) Bone Marrow Transplantation Nephropathy =Disease or Syndrome
|
- 38. BMP15
- [This gene is involved in signal transduction during oogenesis. ( NCI )] (UMLS (NCI) C1332423) BMP15 Gene;
Bone Morphogenetic Protein 15 Gene;
=Gene or Genome | - 82. BMX
- [This gene plays a role in development. It is also involved in both cell growth and differentiation. ( NCI )] (UMLS (NCI) C1332433) BMX Gene;
BMX Non-Receptor Tyrosine Kinase Gene;
=Gene or Genome ;
◊ [Expressed in bone marrow and endothelia by human BMX Gene, intracellular 80-kD BMX Non-Receptor Tyrosine Kinase is a member of the non-receptor tyrosine kinase family (contain an SH3 and SH2 domain upstream of the TK domain) that includes TEC, TXK, ITK, and BTK; homologs of Src28 TK (Drosophila). BMX may play a role in growth and differentiation of hematopoietic cells. There is no obvious phenotype associated with loss of BMX function, suggesting that this tyrosine kinase has a redundant role in arterial endothelial signal transduction. (NCI) ( NCI )] (UMLS (NCI) C1332434) BMX Non-Receptor Tyrosine Kinase; Bone Marrow Kinase BMX; Epithelial and Endothelial Tyrosine Kinase; ETK; NTK38; PSCTK2; PSCTK3 Amino Acid, Peptide, or Protein; Enzyme |
- 39. BMP2
- [Bone Morphogenetic Protein 2, encoded by the BMP2 gene, is a protein that belongs to the transforming growth factor-beta (TGFB) superfamily. By signaling through receptor serine/threonine kinases, Bone morphogenic protein 2 induces bone formation. BMP2 is a candidate gene for the autosomal dominant disease of fibrodysplasia (myositis) ossificans progressiva. (From LocusLink) ( NCI )] (UMLS (NCI) C0527443) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 83. BMY-25801
- (UMLS (NCI) C0950748) =Organic Chemical; Pharmacologic Substance
|
- 40. BMP2
- [This gene plays a role in bone formation via regulation of osteoblast differentiation. It is also involved in cell cycle regulation. ( NCI )] (UMLS (NCI) C1332424) BMP2 Gene;
Bone Morphogenetic Protein 2 Gene;
=Gene or Genome | - 84. BMY-27557-14
- (UMLS (NCI) C0296894) =Organic Chemical; Antibiotic ;
|
- 41. BMP3
- [Bone Morphogenetic Protein 3 (Osteogenic), encoded by the BMP3 gene that belongs to the transforming growth factor-beta (TGFB) superfamily. Bone morphogenic protein 3 induces bone formation by signaling through receptor serine/threonine kinases. It is expressed in lung, ovary and small intestine. The expression signals of BMP3 mRNA in malignant schwannoma are relatively lower than in benign lesions. (From LocusLink, Swiss_Prot and NCI) ( NCI )] (UMLS (NCI) C0069675) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 85. BMY-27857
- (UMLS (NCI) C0701313) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
|
- 42. BMP3
- [This gene is involved in bone and cartilage formation. It plays a role in the negative regulation of bone density. ( NCI )] (UMLS (NCI) C1332425) BMP3 Gene;
Bone Morphogenetic Protein 3 Gene;
=Gene or Genome | - 86. BMY-28090
- (UMLS (NCI) C0950684) =Organic Chemical; Antibiotic
|
- 43. BMP3B
- [This protein is a member of the bone morphogenetic protein (BMP) family and the TGF-beta superfamily. This group of proteins is characterized by a polybasic proteolytic processing site which is cleaved to produce a mature protein containing seven conserved cysteine residues. The members of this family are regulators of cell growth and differentiation in both embryonic and adult tissues. Studies in mice suggest that the protein encoded by this protein plays a role in skeletal morphogenesis. (LocusLink) ( NCI )] (UMLS (NCI) C0386581) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 87. BMY-45594
- (UMLS (NCI) C1328263) =Organic Chemical; Pharmacologic Substance ;
|
- 44. BMP4
- [ ] (UMLS (CSP) C0530979) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 88. BMYB
- [A MYB family transcription factor, B-MYB Protein is essential during cell cycle progression; MYBL2 activates CDC2 and cyclin D1 gene expression in proliferating fibroblasts. MYBL2 expression is regulated at the G1/S transition, and its transcription relies on E2F activity in a cell cycle-dependent manner. MYBL2 transcripts are detectable in a variety of dividing cell types. (from OMIM 601415 and NCI) ( NCI )] (UMLS (NCI) C1505106) BMYB Gene Product;
B-MYB Protein;
MYBL2;
MYB-Related Protein B =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
home
